June 17, 2020 / 12:11 PM / 17 days ago

BRIEF-Cyclo Therapeutics Reports On 18 Month Expanded Access Program In Single Alzheimer's Patient

June 17 (Reuters) - Ctd Holdings Inc:

* CYCLO THERAPEUTICS REPORTS ON EIGHTEEN MONTH EXPANDED ACCESS PROGRAM IN SINGLE ALZHEIMER’S PATIENT

* CTD HOLDINGS INC - FAVORABLE RISK/BENEFIT ANALYSIS OUTLINED IN REPORT TO FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below